{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:30:16Z","timestamp":1791469816176,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"US National Institutes of Health\/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","award":["F32AR062927"],"award-info":[{"award-number":["F32AR062927"]}]},{"name":"US National Institutes of Health\/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","award":["R01AR064251"],"award-info":[{"award-number":["R01AR064251"]}]},{"name":"US National Institutes of Health\/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","award":["R01AR060364"],"award-info":[{"award-number":["R01AR060364"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.joca.2015.09.005","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T00:22:59Z","timestamp":1443313379000},"page":"299-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-5757","authenticated-orcid":false,"given":"R.E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2698-4143","authenticated-orcid":false,"given":"S.","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-0384","authenticated-orcid":false,"given":"A.M.","family":"Malfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2015.09.005_bib1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2174\/138945010791011884","article-title":"Novel therapies in OA","volume":"11","author":"Flannery","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.joca.2015.09.005_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.joca.2009.04.009","article-title":"OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?","volume":"17","author":"Hellio Le Graverand-Gastineau","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11926-013-0350-2","article-title":"Genetically engineered mouse models reveal the importance of proteases as osteoarthritis drug targets","volume":"15","author":"Miller","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.joca.2015.09.005_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/138945010791011956","article-title":"Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis \u2013 insights from studies of aggrecan and collagen proteolysis?","volume":"11","author":"Little","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.joca.2015.09.005_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/art.22334","article-title":"Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5","volume":"56","author":"Song","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2015.09.005_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nature03369","article-title":"Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis","volume":"434","author":"Glasson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.joca.2015.09.005_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature03417","article-title":"ADAMTS5 is the major aggrecanase in mouse cartilage in\u00a0vivo and in\u00a0vitro","volume":"434","author":"Stanton","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.joca.2015.09.005_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.joca.2009.11.013","article-title":"ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization","volume":"18","author":"Malfait","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib9","doi-asserted-by":"crossref","first-page":"20602","DOI":"10.1073\/pnas.1209294110","article-title":"CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis","volume":"109","author":"Miller","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.joca.2015.09.005_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.joca.2015.02.778","article-title":"Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification","volume":"23","author":"Larkin","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib11","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1021\/jm501522n","article-title":"Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis","volume":"57","author":"Durham","year":"2014","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.joca.2015.09.005_bib12","first-page":"S56","article-title":"Selective aggrecanase inhibition is disease modifying and pain alleviating in a rat meniscal tear model of osteoarthritis. 2009 World Congress on osteoarthritis","volume":"17","author":"Glasson","year":"2009","journal-title":"Montreal: Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13075-015-0747-6","article-title":"On the predictive utility of animal models of osteoarthritis","volume":"7","author":"Malfait","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2015.09.005_bib14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","article-title":"The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse","volume":"15","author":"Glasson","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib15","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.38876","article-title":"Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms","volume":"66","author":"Jackson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2015.09.005_bib16","doi-asserted-by":"crossref","first-page":"e54633","DOI":"10.1371\/journal.pone.0054633","article-title":"Disease progression and phasic changes in gene expression in a mouse model of osteoarthritis","volume":"8","author":"Loeser","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"10.1016\/j.joca.2015.09.005_bib17","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","article-title":"The OARSI histopathology initiative \u2013 recommendations for histological assessments of osteoarthritis in the mouse","volume":"18","author":"Glasson","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1016\/j.joca.2015.09.005_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.joca.2015.09.005_bib20","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.joca.2013.08.015","article-title":"Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis","volume":"21","author":"Chiusaroli","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/joca.2000.0363","article-title":"The STR\/ort mouse and its use as a model of osteoarthritis","volume":"9","author":"Mason","year":"2001","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.joca.2008.09.018","article-title":"ADAMTS5\u2212\/\u2212 mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes","volume":"17","author":"Botter","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib23","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2015.09.005_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.gep.2009.02.006","article-title":"Adamts5, the gene encoding a proteoglycan-degrading metalloprotease, is expressed by specific cell lineages during mouse embryonic development and in adult tissues","volume":"9","author":"McCulloch","year":"2009","journal-title":"Gene Expr Patterns"},{"key":"10.1016\/j.joca.2015.09.005_bib25","doi-asserted-by":"crossref","first-page":"e0123342","DOI":"10.1371\/journal.pone.0123342","article-title":"Differential transcriptional profiling of damaged and intact adjacent dorsal root ganglia neurons in neuropathic pain","volume":"10","author":"Reinhold","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2015.09.005_bib26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1302\/0301-620X.87B10.16700","article-title":"The response to injury in the peripheral nervous system","volume":"87","author":"Hall","year":"2005","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.joca.2015.09.005_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0736-5748(96)00017-2","article-title":"Growth cone behavior in the presence of soluble chondroitin sulfate proteoglycan (CSPG), compared to behavior on CSPG bound to laminin or fibronectin","volume":"14","author":"Snow","year":"1996","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.joca.2015.09.005_bib28","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/ar4037","article-title":"Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development","volume":"14","author":"Cook","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2015.09.005_bib29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.joca.2010.06.007","article-title":"Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease","volume":"18","author":"Strassle","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2015.09.005_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/aps.2012.28","article-title":"Efficacy of zoledronic acid in treatment of osteoarthritis is dependent on the disease progression stage in rat medial meniscal tear model","volume":"33","author":"Yu","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.joca.2015.09.005_bib31","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2013-203260","article-title":"Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis","volume":"73","author":"Sagar","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2015.09.005_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.rdc.2014.07.012","article-title":"Identifying and treating preclinical and early osteoarthritis","volume":"40","author":"Felson","year":"2014","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458415013199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458415013199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:39:12Z","timestamp":1761017952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458415013199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1063458415013199"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2015.09.005","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2015.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}